Lv5
1114 积分 2024-07-04 加入
Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells
1个月前
已完结
Recent advancements at ASCO 2024 in PD-L1 and PD-1 bispecific antibodies
1个月前
已完结
PD-L1 peptides in cancer immunoimaging and immunotherapy
1个月前
已完结
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
1个月前
已完结
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL
1个月前
已完结
Acute lymphocytic leukaemia
1个月前
已完结
B‐cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification
1个月前
已完结
Allogeneic Donor-Derived Anti-CD19 CAR T Cell Is a Promising Therapy for Relapsed/Refractory B-ALL After Allogeneic Hematopoietic Stem-Cell Transplantation
1个月前
已完结
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
1个月前
已完结
Genome Editing for Engineering the Next Generation of Advanced Immune Cell Therapies
1个月前
已完结
皖公网安备34019202002308
